Cargando…

Stakeholder knowledge and attitudes toward the use of predictive genetic testing in South Africa

The use of predictive genetic testing, particularly for risk profiling in non-communicable diseases (NCDs), has the potential to benefit public health by decreasing the disease burden and alleviating the pressure on healthcare. It is thus important to assess knowledge and uptake among stakeholders....

Descripción completa

Detalles Bibliográficos
Autores principales: Naidoo, Levani, Reddy, Poovendhree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462643/
https://www.ncbi.nlm.nih.gov/pubmed/36085342
http://dx.doi.org/10.1007/s12687-022-00606-y
_version_ 1784787232397197312
author Naidoo, Levani
Reddy, Poovendhree
author_facet Naidoo, Levani
Reddy, Poovendhree
author_sort Naidoo, Levani
collection PubMed
description The use of predictive genetic testing, particularly for risk profiling in non-communicable diseases (NCDs), has the potential to benefit public health by decreasing the disease burden and alleviating the pressure on healthcare. It is thus important to assess knowledge and uptake among stakeholders. This study aimed to assess end users’ (community, medical practitioners and medical students) knowledge and attitudes regarding the use and support of genomic medicine. A descriptive cross-sectional survey was conducted in Kwazulu-Natal (KZN) among 3 groups of stakeholders (n = 170): medical practitioners from both private and public healthcare, medical students from UKZN and community members represented by teachers. Three structured questionnaires using a Likert scale were administered. Responses were stratified by practice type, and a scoring scale was developed. Principal component analysis (PCA) was used to reduce data on all constructs that made up each variable. All three groups showed adequate knowledge and a positive attitude towards use, apart from medical students who were not as keen to support future use in their own practice. Although medical practitioners supported the use of this technology, with necessary guidelines, expertise and affordability, only 18% from private practice reported having used it. PCA reduced data to fewer parsimonious constructs for all 3 groups: common threads included an awareness that genetic testing may improve health and disease outcomes; guidelines for use; and the provision of education to increase awareness, training to bolster expertise and confidence to use these services. Participants in this study attributed a lack of uptake to limited expertise and professional support, and a lack of legislative guidelines. We recommend updating continuing professional development for medical practitioners and promoting community education concomitantly. Provision of guidelines and increased accessibility to resources are important. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12687-022-00606-y.
format Online
Article
Text
id pubmed-9462643
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-94626432022-09-10 Stakeholder knowledge and attitudes toward the use of predictive genetic testing in South Africa Naidoo, Levani Reddy, Poovendhree J Community Genet Original Article The use of predictive genetic testing, particularly for risk profiling in non-communicable diseases (NCDs), has the potential to benefit public health by decreasing the disease burden and alleviating the pressure on healthcare. It is thus important to assess knowledge and uptake among stakeholders. This study aimed to assess end users’ (community, medical practitioners and medical students) knowledge and attitudes regarding the use and support of genomic medicine. A descriptive cross-sectional survey was conducted in Kwazulu-Natal (KZN) among 3 groups of stakeholders (n = 170): medical practitioners from both private and public healthcare, medical students from UKZN and community members represented by teachers. Three structured questionnaires using a Likert scale were administered. Responses were stratified by practice type, and a scoring scale was developed. Principal component analysis (PCA) was used to reduce data on all constructs that made up each variable. All three groups showed adequate knowledge and a positive attitude towards use, apart from medical students who were not as keen to support future use in their own practice. Although medical practitioners supported the use of this technology, with necessary guidelines, expertise and affordability, only 18% from private practice reported having used it. PCA reduced data to fewer parsimonious constructs for all 3 groups: common threads included an awareness that genetic testing may improve health and disease outcomes; guidelines for use; and the provision of education to increase awareness, training to bolster expertise and confidence to use these services. Participants in this study attributed a lack of uptake to limited expertise and professional support, and a lack of legislative guidelines. We recommend updating continuing professional development for medical practitioners and promoting community education concomitantly. Provision of guidelines and increased accessibility to resources are important. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12687-022-00606-y. Springer Berlin Heidelberg 2022-09-09 2022-12 /pmc/articles/PMC9462643/ /pubmed/36085342 http://dx.doi.org/10.1007/s12687-022-00606-y Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
spellingShingle Original Article
Naidoo, Levani
Reddy, Poovendhree
Stakeholder knowledge and attitudes toward the use of predictive genetic testing in South Africa
title Stakeholder knowledge and attitudes toward the use of predictive genetic testing in South Africa
title_full Stakeholder knowledge and attitudes toward the use of predictive genetic testing in South Africa
title_fullStr Stakeholder knowledge and attitudes toward the use of predictive genetic testing in South Africa
title_full_unstemmed Stakeholder knowledge and attitudes toward the use of predictive genetic testing in South Africa
title_short Stakeholder knowledge and attitudes toward the use of predictive genetic testing in South Africa
title_sort stakeholder knowledge and attitudes toward the use of predictive genetic testing in south africa
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462643/
https://www.ncbi.nlm.nih.gov/pubmed/36085342
http://dx.doi.org/10.1007/s12687-022-00606-y
work_keys_str_mv AT naidoolevani stakeholderknowledgeandattitudestowardtheuseofpredictivegenetictestinginsouthafrica
AT reddypoovendhree stakeholderknowledgeandattitudestowardtheuseofpredictivegenetictestinginsouthafrica